JCR Pharmaceuticals Co. Ltd. | Income Statement
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
15,706
16,856
17,438
18,085
20,594
23,160
Cost of Goods Sold (COGS) incl. D&A
5,842
5,741
6,459
5,732
6,128
6,567
Gross Income
9,864
11,115
10,979
12,353
14,466
16,593
SG&A Expense
8,318
9,047
8,826
9,991
10,681
11,625
EBIT
1,545
2,068
2,153
2,362
3,785
4,968
Unusual Expense
137
20
8
38
33
63
Non Operating Income/Expense
328
293
304
182
83
24
Interest Expense
44
38
33
29
27
21
Pretax Income
1,677
2,334
2,459
2,493
3,895
4,928
Income Tax
381
652
670
630
825
1,217
Consolidated Net Income
1,296
1,682
1,790
1,863
3,069
3,710
Net Income
1,296
1,682
1,789
1,863
3,069
3,714
Net Income After Extraordinaries
1,296
1,682
1,789
1,863
3,069
3,714
Net Income Available to Common
1,296
1,682
1,789
1,863
3,070
3,715
EPS (Basic)
40.79
52.85
56.12
58.95
98.72
120.68
Basic Shares Outstanding
32
32
32
32
31
31
EPS (Diluted)
40.52
52.53
55.81
58.61
98.10
119.96
Diluted Shares Outstanding
32
32
32
32
31
31
EBITDA
2,657
3,420
3,560
3,810
5,167
6,311
Non-Operating Interest Income
34
31
27
17
20
20
Minority Interest Expense
-
-
-
-
-
4
Equity in Affiliates (Pretax)
50
-
-
-
-
-
About JCR Pharmaceuticals Co.
View Profile
